Literature DB >> 23442133

Factors influencing pharmacy services in opioid substitution treatment.

Betty B Chaar1, Holly Wang, Carolyn A Day, Jane R Hanrahan, Adam R Winstock, Romano Fois.   

Abstract

INTRODUCTION AND AIM: Heroin dependence is a serious health burden in Australia. Opioid substitution treatment (OST) has been delivered in Australian community pharmacies since 1985. The effectiveness of pharmacy-based OST is evident and the demand is increasing; however, the participation rate of community pharmacies is low, with over 60% non-providers. While previous Australian studies have focused on perspectives of community pharmacists providing the service, the views of non-providers have not yet been explored. This study aimed to further investigate factors influencing pharmacists' participation in provision of OST in the community pharmacy setting in New South Wales, Australia. DESIGN AND METHODS: Semi-structured interviews were conducted with 35 NSW community pharmacists (20 providers, 15 non-providers). Transcripts of interviews were thematically analysed.
RESULTS: Factors influencing non-providers were mainly stigma and fear, the nature of an opt-in scheme, professionals' moral responsibilities, lack of awareness and knowledge, disproportionate distribution of clients and lack of financial support for OST clients. Providers were motivated by positive attitudes, functional relationships with OST clients/stakeholders, professional satisfaction and financial rewards. Recommendations to improve participation in OST services were offered by both groups. DISCUSSION AND
CONCLUSION: This study explored views from both OST providers and non-providers, revealing a number of previously undocumented barriers that affect the uptake of OST provision in New South Wales community pharmacies. There were also profound ethical issues raised for consideration. These findings may help inform future policies aimed at encouraging pharmacists' provision of OST, to address the unmet needs of the ever-increasing number of heroin-dependent clients in the community.
© 2013 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  Australian pharmacist; disproportionate distribution of clientele; pharmacy OST service; professionals' moral responsibility; providers' and non-providers' perspective

Mesh:

Year:  2013        PMID: 23442133     DOI: 10.1111/dar.12032

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  12 in total

1.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

2.  Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study.

Authors:  Daniel J Ventricelli; Stephanie M Mathis; Kelly N Foster; Robert P Pack; Fred Tudiver; Nicholas E Hagemeier
Journal:  Subst Use Misuse       Date:  2019-10-08       Impact factor: 2.164

3.  Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky.

Authors:  Hannah Lf Cooper; David H Cloud; Patricia R Freeman; Monica Fadanelli; Travis Green; Connor Van Meter; Stephanie Beane; Umedjon Ibragimov; April M Young
Journal:  Int J Drug Policy       Date:  2020-03-26

4.  Australian Community Pharmacy Harm-Minimisation Services: Scope for Service Expansion to Improve Healthcare Access.

Authors:  Sara S McMillan; Hidy Chan; Laetitia H Hattingh
Journal:  Pharmacy (Basel)       Date:  2021-04-26

5.  The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.

Authors:  Sami Isaac; Bandana Saini; Betty B Chaar
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

6.  Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators.

Authors:  Bethany Wilson; Sara S McMillan; Amanda J Wheeler
Journal:  J Pharm Policy Pract       Date:  2019-08-07

7.  Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders.

Authors:  Paxton Bach; Daniel Hartung
Journal:  Addict Sci Clin Pract       Date:  2019-09-02

8.  Accepting new patients who require opioids into family practice: results from the MAAP-NS census survey study.

Authors:  Emily Gard Marshall; Frederick Burge; Richard J Gibson; Beverley Lawson; Colleen O'Connell
Journal:  BMC Fam Pract       Date:  2019-10-23       Impact factor: 2.497

9.  Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.

Authors:  Li-Tzy Wu; William S John; Eric D Morse; Steve Adkins; Jennifer Pippin; Robert K Brooner; Robert P Schwartz
Journal:  Addiction       Date:  2021-08-16       Impact factor: 6.526

10.  Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries.

Authors:  Theodore M Hammett; Son Phan; Julia Gaggin; Patricia Case; Nicholas Zaller; Alexandra Lutnick; Alex H Kral; Ekaterina V Fedorova; Robert Heimer; Will Small; Robin Pollini; Leo Beletsky; Carl Latkin; Don C Des Jarlais
Journal:  BMC Health Serv Res       Date:  2014-06-17       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.